Adequan i.m (polysulfated glycosaminoglycan) is the only FDA-approved PSGAG for the treatment of degenerative joint disease (DJD) in horses. Unlike treatments that merely mask symptoms, Adequan i.m addresses the root causes of DJD by reducing inflammation, restoring synovial joint lubrication, repairing joint cartilage, and even reversing the disease process. Trusted by veterinarians for over 30 years, Adequan i.m has proven effective across various equine disciplines and levels, enhancing mobility and quality of life for horses.
Key Features:
FDA-Approved: The only polysulfated glycosaminoglycan approved for equine DJD
Comprehensive Treatment: Reduces inflammation, restores joint lubrication, repairs cartilage, and reverses DJD
Trusted for Decades: Over 30 years of proven effectiveness in the equine community
No Generic Equivalent: Unique formulation for specialized treatment of joint dysfunction
Benefits of Adequan i.m. for Horses:
Effective Joint Health: Targets and treats the underlying causes of DJD
Improved Mobility: Helps horses achieve greater freedom of movement and comfort
Veterinarian Recommended: Trusted by equine health professionals for its reliability and results
Why Choose Adequan i.m.?
No Generic Available: Ensures you're getting the specialized, proven formula
Long-Standing Trust: A staple in equine joint health for decades
Holistic Approach: Goes beyond symptom relief to promote overall joint health
For optimal joint health and performance in horses, choose Adequan i.m. Equine. Invest in a treatment that's proven, trusted, and designed to enhance your horse's quality of life by addressing the root causes of degenerative joint disease in horses.
Shipping Restrictions: The following may not be shippable to the specified states: GU, VI
